119 related articles for article (PubMed ID: 2573147)
1. Influence of chronic rioprostil treatment on gastric endocrine function.
Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
[TBL] [Abstract][Full Text] [Related]
2. Rioprostil and the gastric mucus-bicarbonate barrier.
Guslandi M; Fasani R; Tittobello A
Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
[TBL] [Abstract][Full Text] [Related]
3. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
[TBL] [Abstract][Full Text] [Related]
4. Effects of rioprostil on the postprandial glucose, GIP, insulin and gastrin levels in volunteers.
Demol P; Wingender W
Scand J Gastroenterol Suppl; 1989; 164():112-7. PubMed ID: 2510253
[TBL] [Abstract][Full Text] [Related]
5. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
6. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
Katz LB; Genna T; Greeley GH; Shriver DA
Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
[TBL] [Abstract][Full Text] [Related]
8. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
[TBL] [Abstract][Full Text] [Related]
9. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
10. Effects of rioprostil on bicarbonate secretion by guinea-pig gastric mucosa in vitro.
Petersen KU; Winterhager JM
Scand J Gastroenterol Suppl; 1989; 164():26-33; discussion 33-4. PubMed ID: 2510277
[TBL] [Abstract][Full Text] [Related]
11. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers.
Tolman KG; Detweiler MK; Harrison CA; Rollins DE; Simon DA; Brady C; McCormack GH; Bryant EC
J Clin Pharmacol; 1988 Jan; 28(1):76-80. PubMed ID: 3127431
[TBL] [Abstract][Full Text] [Related]
12. Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.
Segers O; Somers G
Dig Dis Sci; 1990 Jan; 35(1):20-6. PubMed ID: 2104796
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
Demol P; Wingender W; Weihrauch TR; Graefe KH
Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
[TBL] [Abstract][Full Text] [Related]
14. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
Shriver DA; Katz LB; Rosenthale ME
Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
[TBL] [Abstract][Full Text] [Related]
15. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
[TBL] [Abstract][Full Text] [Related]
16. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
[TBL] [Abstract][Full Text] [Related]
17. Effect of rioprostil, a synthetic prostaglandin E1 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans.
Schulte K; Singer MV; Eysselein V; Demol P; Goebell H
Digestion; 1987; 36(3):162-7. PubMed ID: 3109990
[TBL] [Abstract][Full Text] [Related]
18. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
Baunack AR; Demol P; Froese G; Kuhlmann J; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():120-5; discussion 125-6. PubMed ID: 2510255
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions between theophylline and rioprostil.
de Lauture D; Rey E; d'Athis P; Richard MO; Paccaly D; Prunieras F; Strauch G; Olive G
Scand J Gastroenterol Suppl; 1989; 164():63-6; discussion 67. PubMed ID: 2510283
[TBL] [Abstract][Full Text] [Related]
20. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
Morris GP; Keenan CM; Shriver DA
Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
